Resultats de la cerca - Dirk Hasenclever

Refinar resultats
  1. 1
    Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's disease

    Rationale for dose escalation of first line conventional chemotherapy in advanced Hodgkin's disease per Dirk Hasenclever, Markus Loeffler, Volker Diehl

    Publicat 1996
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Should Treatment of Hepatitis B Depend on Hepatitis B virus Genotypes? A Hypothesis Generated from an Explorative Analysis of Published Evidence

    Should Treatment of Hepatitis B Depend on Hepatitis B virus Genotypes? A Hypothesis Generated from an Explorative Analysis of Published Evidence per Johannes Wiegand, Dirk Hasenclever, Hans L. Tillmann

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20<sup>+</sup>B-Cell Lymphoma in the Rituximab Era

    Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20<sup>+</sup>B-Cell Lymphoma in the Rituximab Era per Marita Ziepert, Dirk Hasenclever, Evelyn Kuhnt, Bertram Glaß, Norbert Schmitz, Michael Pfreundschuh, Markus Loeffler

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery)

    Remote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery) per Carina Benstoem, Christian Stoppe, Oliver J. Liakopoulos, Julia Ney, Dirk Hasenclever, Patrick Meybohm, Andreas Goetzenich

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease

    Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease per Angela Gause, Christoph Pohl, Astrid Tschiersch, L. Da Costa, W. Jung, Volker Diehl, Dirk Hasenclever, Michael Pfreundschuh

    Publicat 1991
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogastric junction cancer patients undergoing first-line treatment from the phase III EXPAND trial

    Modified Glasgow prognostic score (mGPS) is correlated with sarcopenia and dominates the prognostic role of baseline body composition parameters in advanced gastric and esophagogas... per Ulrich Hacker, Dirk Hasenclever, R. Baber, Nicolas Linder, Harald Busse, Radka Obermannová, Lenka Zdražilová Dubská, Dalibor Valík, Florian Lordick

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial

    Prognostic role of body composition parameters in gastric/gastroesophageal junction cancer patients from the EXPAND trial per Ulrich Hacker, Dirk Hasenclever, Nicolas Linder, Gertraud Stocker, Hyun Cheol Chung, Yoon‐Koo Kang, Markus Moehler, Harald Busse, Florian Lordick

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease

    BEACOPP: An intensified chemotherapy regimen in advanced Hodgkin's disease per Volker Diehl, M. Sieber, U. Rüffer, B. Lathan, Dirk Hasenclever, Michael Pfreundschuh, Markus Loeffler, D. Lieberz, P. Koch, Michael Adler, Hans Tesch

    Publicat 1997
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgkin's disease

    Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advanced Hodgk... per Volker Diehl, Markus Loeffler, Michael Pfreundschuh, U. Ruehl, Dirk Hasenclever, Hiltrud Nisters-Backes, M. Sieber, Kirby L. Smith, Hans Tesch, Wilhelm Geilen

    Publicat 1995
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

    Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease per Volker Diehl, Jeremy Franklin, Michael Pfreundschuh, B. Lathan, Ursula Paulus, Dirk Hasenclever, Hans Tesch, Richard Herrmann, Bernd Dörken, Hans–Konrad Müller–Hermelink, E. Dühmke, Markus Loeffler

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Resection alone in 58 children with limited stage, lymphocyte‐predominant Hodgkin lymphoma–experience from the European network group on pediatric Hodgkin lymphoma

    Resection alone in 58 children with limited stage, lymphocyte‐predominant Hodgkin lymphoma–experience from the European network group on pediatric Hodgkin lymphoma per Christine Mauz‐Körholz, S. Gorde-Grosjean, Dirk Hasenclever, Ananth Shankar, W Dörffel, William H. Wallace, G. Schellong, Alain Robert, Dieter Körholz, Odile Oberlin, Georgina Hall, Judith Landman‐Parker

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

    Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma per Wolfram Klapper, Markus Kreuz, Christian Köhler, Birgit Burkhardt, Monika Szczepanowski, Itziar Salaverría, Michael Hummel, Markus Loeffler, Shoji Pellissery, Wilhelm Woessmann, Carsten Schwänen, Lorenz Trümper, Swen Weßendorf, Rainer Spang, Dirk Hasenclever, Reiner Siebert

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Antibodies in the Diagnosis of Coeliac Disease: A Biopsy-Controlled, International, Multicentre Study of 376 Children with Coeliac Disease and 695 Controls

    Antibodies in the Diagnosis of Coeliac Disease: A Biopsy-Controlled, International, Multicentre Study of 376 Children with Coeliac Disease and 695 Controls per Johannes Wolf, Dirk Hasenclever, David Petroff, Thomas Richter, Holm H. Uhlig, Martin W. Laaβ, Almuthe Hauer, Martin Stern, Xavier Bossuyt, Jan de Laffolie, Gunter Flemming, Danilo Villalta, Wolfgang Schlumberger, Thomas Mothes

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group

    Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet... per Stephen Daw, Dirk Hasenclever, Maurizio Mascarin, Ana Fernández‐Teijeiro, Walentyna Balwierz, Auke Beishuizen, Roberta Burnelli, Michaela Čepelová, Alexander Claviez, Karin Dieckmann, Judith Landman‐Parker, Regine Kluge, Dieter Körholz, Christine Mauz‐Körholz, William H. Wallace, Thierry Leblanc

    Publicat 2020
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  15. 15
    Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

    Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer per Marcus Schmidt, Dirk Hasenclever, Mitra Schaeffer, Daniel Boehm, Cristina Cotarelo, Eric Steiner, Antje Lebrecht, Wulf Siggelkow, W. Weikel, Ilka Schiffer-Petry, Susanne Gebhard, Henryk Pilch, Mathias Gehrmann, Hans‐Anton Lehr, Heinz Koelbl, Jan G. Hengstler, Martin Schüler

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy

    Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy per Johannes Wolf, David Petroff, Thomas Richter, Marcus Auth, Holm H. Uhlig, Martin W. Laaß, Peter Lauenstein, Andreas Krahl, Norman Händel, Jan de Laffolie, Almuthe Hauer, Thomas Kehler, Gunter Flemming, Frank P. Schmidt, Astor Rodrigues, Dirk Hasenclever, Thomas Mothes

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study

    Procarbazine-Free OEPA-COPDAC Chemotherapy in Boys and Standard OPPA-COPP in Girls Have Comparable Effectiveness in Pediatric Hodgkin's Lymphoma: The GPOH-HD-2002 Study per Christine Mauz‐Körholz, Dirk Hasenclever, W Dörffel, Kathrin Ruschke, Tanja Pelz, Antje Voigt, Martina Stiefel, Melanie Winkler, Constanze Vilser, Karin Dieckmann, Jonas Karlén, Eva Bergsträßer, Alexander Fosså, Georg Mann, Michael Hummel, Wolfram Klapper, Harald Stein, Dirk Vordermark, Regine Kluge, Dieter Körholz

    Publicat 2010
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

    Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study per Andreas Engert, Volker Diehl, Jeremy Franklin, Andreas Lohri, Bernd Dörken, Wolf‐Dieter Ludwig, P. Koch, Mathias Hänel, Michael Pfreundschuh, Martin Wilhelm, Lorenz Trümper, Walter-Erich Aulitzky, Martin Bentz, Mathias Rummel, Orhan Sezer, Hans–Konrad Müller–Hermelink, Dirk Hasenclever, Markus Löffler

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma

    Inter-Reader Reliability of Early FDG-PET/CT Response Assessment Using the Deauville Scale after 2 Cycles of Intensive Chemotherapy (OEPA) in Hodgkin’s Lymphoma per Regine Kluge, Lidia Chavdarova, Martha Hoffmann, Carsten Kobe, Bogdan Małkowski, Françoise Montravers, Lars Kurch, Thomas Georgi, Markus Dietlein, William H. Wallace, Jonas Karlén, Ana Fernández‐Teijeiro, Michaela Čepelová, L Wilson, Eva Bergstraesser, Osama Sabri, Christine Mauz‐Körholz, Dieter Körholz, Dirk Hasenclever

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma

    [<sup>18</sup>F]Fluorodeoxyglucose Positron Emission Tomography for Detection of Bone Marrow Involvement in Children and Adolescents With Hodgkin's Lymphoma per Sandra Purz, Christine Mauz‐Körholz, Dieter Körholz, Dirk Hasenclever, Annaliese Krausse, Ina Sorge, Kathrin Ruschke, Martina Stiefel, Holger Amthauer, Otmar Schober, W. T. Kranert, Wolfgang Weber, Uwe Haberkorn, Patrick Hundsdörfer, Karoline Ehlert, Martina Becker, Jochen Rößler, Andreas E. Kulozik, Osama Sabri, Regine Kluge

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: